Literature DB >> 25754079

Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder.

C Yuksel1,2, F Du1,2, C Ravichandran1,2, J R Goldbach1, T Thida1,3, P Lin1,2,4, B Dora1,5, J Gelda1,6, L O'Connor1, S Sehovic1,7, S Gruber1,2, D Ongur1,2, B M Cohen1,2.   

Abstract

Converging evidence suggests bioenergetic abnormalities in bipolar disorder (BD). In the brain, phosphocreatine (PCr) acts a reservoir of high-energy phosphate (HEP) bonds, and creatine kinases (CK) catalyze the transfer of HEP from adenosine triphosphate (ATP) to PCr and from PCr back to ATP, at times of increased need. This study examined the activity of this mechanism in BD by measuring the levels of HEP molecules during a stimulus paradigm that increased local energy demand. Twenty-three patients diagnosed with BD-I and 22 healthy controls (HC) were included. Levels of phosphorus metabolites were measured at baseline and during visual stimulation in the occipital lobe using (31)P magnetic resonance spectroscopy at 4T. Changes in metabolite levels showed different patterns between the groups. During stimulation, HC had significant reductions in PCr but not in ATP, as expected. In contrast, BD patients had significant reductions in ATP but not in PCr. In addition, PCr/ATP ratio was lower at baseline in patients, and there was a higher change in this measure during stimulation. This pattern suggests a disease-related failure to replenish ATP from PCr through CK enzyme catalysis during tissue activation. Further studies measuring the CK flux in BD are required to confirm and extend this finding.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25754079     DOI: 10.1038/mp.2015.13

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  61 in total

Review 1.  Non-invasive methods for studying brain energy metabolism: what they show and what it means.

Authors:  G J Kemp
Journal:  Dev Neurosci       Date:  2000 Sep-Dec       Impact factor: 2.984

2.  Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.

Authors:  Samira S Valvassori; Gislaine T Rezin; Camila L Ferreira; Morgana Moretti; Cinara L Gonçalves; Mariana R Cardoso; Emílio L Streck; Flávio Kapczinski; João Quevedo
Journal:  J Psychiatr Res       Date:  2010-03-23       Impact factor: 4.791

3.  Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons.

Authors:  G J Brewer; T W Wallimann
Journal:  J Neurochem       Date:  2000-05       Impact factor: 5.372

4.  Abnormal frontal lobe phosphorous metabolism in bipolar disorder.

Authors:  R F Deicken; G Fein; M W Weiner
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

5.  Antipsychotic treatment alters protein expression associated with presynaptic function and nervous system development in rat frontal cortex.

Authors:  Dan Ma; Man K Chan; Helen E Lockstone; Sandra R Pietsch; Declan N C Jones; Jackie Cilia; Mark D Hill; Melanie J Robbins; Isabel M Benzel; Yagnesh Umrania; Paul C Guest; Yishai Levin; Peter R Maycox; Sabine Bahn
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

6.  Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia.

Authors:  T Kato; T Shioiri; J Murashita; H Hamakawa; T Inubushi; S Takahashi
Journal:  Psychiatry Res       Date:  1995-09-29       Impact factor: 3.222

7.  Brain metabolic alterations in medication-free patients with bipolar disorder.

Authors:  Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2004-05

8.  Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity.

Authors:  T Kato; J Murashita; A Kamiya; T Shioiri; N Kato; T Inubushi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

9.  Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy.

Authors:  Dajung J Kim; In Kyoon Lyoo; Sujung J Yoon; Taeyoung Choi; Byungchol Lee; Jieun E Kim; Joonsun S Lee; Perry F Renshaw
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-04-24       Impact factor: 5.067

10.  Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain.

Authors:  Fabiano R Agostinho; Giselli Scaini; Gabriela K Ferreira; Isabela C Jeremias; Gislaine Z Réus; Gislaine T Rezin; Adalberto A Castro; Alexandra I Zugno; João Quevedo; Emilio L Streck
Journal:  Brain Res Bull       Date:  2009-09-11       Impact factor: 4.077

View more
  23 in total

1.  A nested phosphorus and proton coil array for brain magnetic resonance imaging and spectroscopy.

Authors:  Ryan Brown; Karthik Lakshmanan; Guillaume Madelin; Prodromos Parasoglou
Journal:  Neuroimage       Date:  2015-09-13       Impact factor: 6.556

2.  Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015.

Authors:  Gwyneth Zai; Bonnie Alberry; Janine Arloth; Zsófia Bánlaki; Cristina Bares; Erik Boot; Caroline Camilo; Kartikay Chadha; Qi Chen; Christopher B Cole; Katherine T Cost; Megan Crow; Ibene Ekpor; Sascha B Fischer; Laura Flatau; Sarah Gagliano; Umut Kirli; Prachi Kukshal; Viviane Labrie; Maren Lang; Tristram A Lett; Elisabetta Maffioletti; Robert Maier; Marina Mihaljevic; Kirti Mittal; Eric T Monson; Niamh L O'Brien; Søren D Østergaard; Ellen Ovenden; Sejal Patel; Roseann E Peterson; Jennie G Pouget; Diego L Rovaris; Lauren Seaman; Bhagya Shankarappa; Fotis Tsetsos; Andrea Vereczkei; Chenyao Wang; Khethelo Xulu; Ryan K C Yuen; Jingjing Zhao; Clement C Zai; James L Kennedy
Journal:  Psychiatr Genet       Date:  2016-12       Impact factor: 2.458

3.  Abnormalities in High-Energy Phosphate Metabolism in First-Episode Bipolar Disorder Measured Using 31P-Magnetic Resonance Spectroscopy.

Authors:  Fei Du; Cagri Yuksel; Virginie-Anne Chouinard; Polly Huynh; Kyle Ryan; Bruce M Cohen; Dost Öngür
Journal:  Biol Psychiatry       Date:  2017-04-07       Impact factor: 13.382

4.  Antimanic Treatment With Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study.

Authors:  Ayşegül Yildiz; Burç Aydin; Necati Gökmen; Ayşegül Yurt; Bruce Cohen; Pembe Keskinoglu; Dost Öngür; Perry Renshaw
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-03

Review 5.  Targeting Mitochondrial Dysfunction for Bipolar Disorder.

Authors:  Maya Kuperberg; Sophie L A Greenebaum; Andrew A Nierenberg
Journal:  Curr Top Behav Neurosci       Date:  2021

6.  Brain bioenergetics and redox state measured by 31P magnetic resonance spectroscopy in unaffected siblings of patients with psychotic disorders.

Authors:  Virginie-Anne Chouinard; Sang-Young Kim; Linda Valeri; Cagri Yuksel; Kyle P Ryan; Guy Chouinard; Bruce M Cohen; Fei Du; Dost Öngür
Journal:  Schizophr Res       Date:  2017-03-01       Impact factor: 4.939

7.  Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies.

Authors:  Asli Ercan Dogan; Cagri Yuksel; Fei Du; Virginie-Anne Chouinard; Dost Öngür
Journal:  Neuropsychopharmacology       Date:  2018-03-14       Impact factor: 7.853

8.  Impaired sensory processing measured by functional MRI in Bipolar disorder manic and depressed mood states.

Authors:  Joseph J Shaffer; Casey P Johnson; Jess G Fiedorowicz; Gary E Christensen; John A Wemmie; Vincent A Magnotta
Journal:  Brain Imaging Behav       Date:  2018-06       Impact factor: 3.978

9.  Grey and white matter alteration in euthymic children with bipolar disorder: a combined source-based morphometry (SBM) and voxel-based morphometry (VBM) study.

Authors:  Anshita Singh; Amit Arya; Vivek Agarwal; Raj Shree; Uttam Kumar
Journal:  Brain Imaging Behav       Date:  2021-04-12       Impact factor: 3.978

10.  Effect of blueberry extract on energetic metabolism, levels of brain-derived neurotrophic factor, and Ca2+-ATPase activity in the hippocampus and cerebral cortex of rats submitted to ketamine-induced mania-like behavior.

Authors:  Luiza Spohr; Mayara Sandrielly Pereira Soares; Natália Pontes Bona; Nathalia Stark Pedra; Alethéa Gatto Barschak; Rafaela Martins Alvariz; Marcia Vizzotto; Claiton Leoneti Lencina; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Metab Brain Dis       Date:  2022-01-19       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.